Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-03-06
1993-08-31
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514260, 544284, 544287, 544289, A61K 31505, A01N 4354, C07D23990, C07D23991
Patent
active
052409287
ABSTRACT:
Novel substituted quinazolinones of the formula (I), which are useful as angiotensin II antagonists, are disclosed. ##STR1##
REFERENCES:
patent: 3936453 (1976-02-01), Hardtmann
patent: 4880804 (1989-11-01), Carini et al.
Chiu et al, "Non-Peptide Angiotensin II Receptor Antagonists . . . " European Journal of Pharmacology 157(1988) 13-21.
Wong et al., European Journal of Pharmacology, 202, pp. 323-330 (1991).
Allen Eric E.
Chakravarty Prasun K.
de Laszlo Stephen E.
Greenlee William J.
Patchett Arthur A.
DiPrima Joseph F.
Grumbling Matthew V.
Merck & Co. , Inc.
North Robert J.
Shah Mukund J.
LandOfFree
Substituted quinazolinones as angiotensin II antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted quinazolinones as angiotensin II antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted quinazolinones as angiotensin II antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2297509